It has been reported that in gastric cancer, MFAP2 plays an important role in regulating the integrin signaling pathway in tumor cell ECM interaction as an integrin/FAK/ERK1/2 signaling activator during gastric cancer progression (25). Here, MAPK3 is linked to gastric cancer.